Our structure

Our work is focused on five areas covering public affairs, regulatory affairs, influenza, access to vaccines, and research and development.

Executive board

Florence
Baron-Papillon
President (Sanofi)
Juan Carlos
Jaramillo
Vice-President (Valneva)
Deborah
Scarano
Treasurer (Pfizer)
Andreas
Potthoff
(Abbott)
Sharon
McHale
(CSL Seqirus)
Guillermo
De Juan Echávarri
(GSK)
Jürgen
Betzing
(IDT Biologika)
Jurgen
Kwik
(Janssen/JnJ)
Nicoletta
Luppi
(MSD)
Kelly
Cappio
(Novavax)
Theodore
Tsai
(Takeda)
Charbel
Harber
(Moderna)

Executive office

Sibilia
Quilici
Executive Director
Laurent
Louette
Director Public Affairs & Country Liaison
Anna
Czwarno
Director, Regulatory and R&D
Anna
Vicere
Senior Manager, Access Policy & Public Affairs
Andreea
Iordache
Junior Manager Science & Regulatory Affairs
Polina
Zoteva
Communications Lead
Anne
Meynaerts
Administrative Assistant

Working Group Chairs